Cart development history



  • December, 2013
    Cancer immunotherapy voted "Breakthrough of the Year Science magazine votes cancer immunotherapy the 2013 “Breakthrough of the Year.” Among the approaches discussed is CAR T cell therapy.

  • October, 2014
    US reports show that CAR-T treatment of advanced acute B lymphocytic leukemia (B-ALL) 90% complete response rate in clinical studies (complete remission for 5 years without recurrence is a clinical cure).

  • January, 2015
    US President Barack Obama met Emily Whitehead - 3.The first child patient receiving CAR-T treatment. Emily 6 years old in Philadelphia children The hospital received CAR-T treatment and the tumor is now fully recovered.

  • August, 2017
    US time August 30, 2017, the US FDA approved Novartis :KYMRIAH listed

  • October, 2017
    October 18, 201, US time, the US FDA approved the second paragraph of the world CAR-T products YESCARTA listed